Cytovance® Biologics is a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO) that excels in the rapid and cost-effective development and manufacture of large molecule APIs from both mammalian cell culture and microbial fermentation such as monoclonal antibodies, fragment antibodies, bispecifics, enzymes, fusion proteins, vaccines and other biological products including plasmid DNA and cell-based therapeutics. In addition to our clinical and commercial cGMP API manufacturing services, Cytovance offers well integrated development services supporting the entire product lifecycle including cell line development, cell banking, microbial strain development, process and analytical development, and process characterization. A centralized, responsive program management team coordinates all critical CMC activities for each client program around raw materials management, QC testing, ICH stability studies, and regulatory support. Our 140,000 sq. ft. state-of-the-art facilities in Oklahoma City are designed to meet U.S., EU, and other global regulatory standards.
Thermo Fisher Scientific
Thermo Fisher Scientific provides industry-leading solutions for drug development, clinical trial logistics and commercial manufacturing to customers through our Patheon brand. Our Patheon Viral Vector Services business specializes in CDMO services for companies developing gene-modified cell therapies and gene therapies. Our key offerings include process and analytical development, clinical and commercial supply of viral vector drug substance and drug product, and regulatory support, enabling our clients to bring novel medicines to market. We are flexible to support every client’s unique product needs, timelines and regulatory pathways. Through recent investments in our world-class facilities and planned expansions, we are strategically positioned to support your immediate and long-term viral vector manufacturing needs.
Our mission is to revolutionize scientific processes and data management in order to accelerate precision health across life sciences. Our end-to-end solutions and services yield efficiencies that enable researchers to make new genomics discoveries. The L7|ESP provides single data and process automation platform for all therapy-related information in a regulatory compliant way that supports better collaboration between all the stakeholders. L7|ESP links disparate systems with connectors to existing systems, apps to view the same data from one system, and interfaces with analytics tools. L7|ESP is easy to implement and user-driven and can overlay existing systems.
Deallus is a unique strategic intelligence consultancy operating across the global life sciences sector. Our mission is simple: to prepare you for the future by delivering the forward-thinking assurance you need in an uncertain and highly competitive world. The knowledge and clarity we provide helps life sciences companies shape future markets by making the right strategic decisions with confidence
Our strong heritage in competitive intelligence has evolved over our 16 years in business to include capabilities well beyond insight gathering. We pair our extensive CI expertise with our deep market understanding and analytical prowess to offer our clients true strategic intelligence services as they navigate complex problem-solving across the entire product life cycle
Our strategic intelligence services
We are a company of experienced and dedicated life sciences specialists. Our unparalleled competitive intelligence capabilities are enhanced by the strategic mindset that drives our entire organisation.
This enables us to provide you with the assured guidance you need to make the right strategic decisions. We are well equipped to assist with any issue at any stage of your product’s lifecycle- we offer a complete range of best-in-class strategic intelligence services.